[On November11, 2013, Shenzhen Mindray Bio-Medical Electronics a subsidiary of Mindray Medical International Limited (Mindray), entered into a settlementreement related to an ordinaryursemmercial dispute with anM manufacturing customer, Beckmanulter Innnection with this settlement, Mindray will take a litigation related charge of approximately $15 million in the fourth quarter of 2013.]
[On November11, 2013, Shenzhen Mindray Bio-Medical Electronics a subsidiary of Mindray Medical International Limited (Mindray), entered into a settlementreement related to an ordinaryursemmercial dispute with anM manufacturing customer, Beckmanulter Innnection with this settlement, Mindray will take a litigation related charge of approximately $15 million in the fourth quarter of 2013.]
[On November11, 2013, Shenzhen Mindray Bio-Medical Electronics a subsidiary of Mindray Medical International Limited (Mindray), entered into a settlementreement related to an ordinaryursemmercial dispute with anM manufacturing customer, Beckmanulter Innnection with this settlement, Mindray will take a litigation related charge of approximately $15 million in the fourth quarter of 2013.]
[Mindray Announces Up to $200 Million Share Repurchase Program Shenzhen, China November 4, 2013 Mindray Medical International Limited (Mindray or Company, NYSE: MR), a leading developer, manufacturer and marketer of medical devices worldwide, today announced that its Board of Directors has approved a share repurchase program. The program is authorized to be in effect starting from today and]
[Mindray Announces Up to $200 Million Share Repurchase Program Shenzhen, China November 4, 2013 Mindray Medical International Limited (Mindray or Company, NYSE: MR), a leading developer, manufacturer and marketer of medical devices worldwide, today announced that its Board of Directors has approved a share repurchase program. The program is authorized to be in effect starting from today and]
[Mindray Announces Third Quarter 2013 Financial Results Shenzhen, China November 4, 2013 Mindray Medical International Limited (NYSE: MR), a leading developer, manufacturer and marketer of medical devices worldwide, announced today its selected unaudited financial results for the third quarter ended September 30, 2013. Highlights for Third Quarter 2013 Net revenues increased 15.3% year-over-year to $296.3 million. International]
[Mindray Announces Third Quarter 2013 Financial Results Shenzhen, China November 4, 2013 Mindray Medical International Limited (NYSE: MR), a leading developer, manufacturer and marketer of medical devices worldwide, announced today its selected unaudited financial results for the third quarter ended September 30, 2013. Highlights for Third Quarter 2013 Net revenues increased 15.3% year-over-year to $296.3 million. International]
[Mindray Announces Up to $200 Million Share Repurchase Program Shenzhen, China November4, 2013 Mindray Medical International Limited (Mindray ormpany, NYSE: MR), a leading developer, manufacturer and marketer of medical devices worldwide, today announced that its Board of Directors has approved a share repurchase program. The program is authorized to be in effect starting from today]
[Mindray Announces Up to $200 Million Share Repurchase Program Shenzhen, China November4, 2013 Mindray Medical International Limited (Mindray ormpany, NYSE: MR), a leading developer, manufacturer and marketer of medical devices worldwide, today announced that its Board of Directors has approved a share repurchase program. The program is authorized to be in effect starting from today]
[Mindray Announces Third Quarter 2013 Financial Results Shenzhen, China November4, 2013 Mindray Medical International Limited (NYSE: MR), a leading developer, manufacturer and marketer of medical devices worldwide, announced today its selected unaudited financial results for the third quarter ended September30, 2013. Highlights for Third Quarter 2013 Net revenuesreased 15.3% year-over-year to $296.3 million. Internationalles grew]
